Helius Medical Technologies files prospectus for up to $25M at-the-market stock offering

Solana Co

Filed updated Prospectus Supplement for sale of up to $25M of common stock.
Sales will be made through Roth Capital Partners as sales agent via at-the-market offerings.
Net proceeds to be used for working capital, commercialization, and R&D activities.
Shares are registered under existing S-3 registration statement.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.